Patent · US Active

Compositions and methods for enhancing coagulation factor VIII function

US10442850B2 · kind B2 · utility

2Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 2017
Grant dateOct 15, 2019
Priority date—
Expiry dateJan 13, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Factor VIII variants and methods of use thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.